| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 744912 | GX15-070 | 0.0237952199154256 | -0.18693276 |
| NSC 746608 | Null | 0.0237952199154256 | -0.093338589 |
| NSC 138333 | Null | 0.0246753314031139 | -0.26847462 |
| NSC 330500 | Macbecin II | 0.0246753314031139 | 0.30131205 |
| NSC 36437 | 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) | 0.0246753314031139 | -0.31314051 |
| NSC 628915 | 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate | 0.0246753314031139 | 0.041909688 |
| NSC 668263 | Null | 0.0246753314031139 | -0.11591684 |
| NSC 685833 | 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- | 0.0246753314031139 | -0.16212107 |
| NSC 691202 | Null | 0.0246753314031139 | -0.12539645 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0252510646170343 | 0.26006863 |